Terms: = Bone cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Treatment
69 results:
1. Determining the risk of spinal pathology progression in neurofibromatosis type 1 patients - a national tertiary neurofibromatosis type 1 centre study.
Robinson D; Biswas S; Torrie C; MacArthur J; Snowdon E; Sial M; Sarkar V; George KJ
Clin Neurol Neurosurg; 2023 Nov; 234():107985. PubMed ID: 37778105
[TBL] [Abstract] [Full Text] [Related]
2. [A case of orbital rhabdomyosarcoma combined with neurofibromatosis type 1 in a child].
Gao L; Zhou JC; Wang Y
Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):305-309. PubMed ID: 37012595
[TBL] [Abstract] [Full Text] [Related]
3. Malignant peripheral nerve sheath tumours in a patient with Neurofibromatosis-1.
Iqbal F; Jamaluddin M; Bukhari F; Islam OS
J Pak Med Assoc; 2023 Feb; 73(2):393-395. PubMed ID: 36800734
[TBL] [Abstract] [Full Text] [Related]
4. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis.
Oh KY; Hong SD
Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181
[TBL] [Abstract] [Full Text] [Related]
5. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
de Blank PMK; Gross AM; Akshintala S; Blakeley JO; Bollag G; Cannon A; Dombi E; Fangusaro J; Gelb BD; Hargrave D; Kim A; Klesse LJ; Loh M; Martin S; Moertel C; Packer R; Payne JM; Rauen KA; Rios JJ; Robison N; Schorry EK; Shannon K; Stevenson DA; Stieglitz E; Ullrich NJ; Walsh KS; Weiss BD; Wolters PL; Yohay K; Yohe ME; Widemann BC; Fisher MJ
Neuro Oncol; 2022 Nov; 24(11):1845-1856. PubMed ID: 35788692
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract] [Full Text] [Related]
7. Spinal screening, malignancy, medical therapy, and surgical correction of deformity in pediatric patients with neurofibromatosis type 1: a systematic review.
Suresh KV; Xu AL; Groves ML; Sponseller PD
J Pediatr Orthop B; 2022 Nov; 31(6):572-582. PubMed ID: 35132000
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics.
Darmawan CC; Ohn J; Mun JH; Kim S; Lim Y; Jo SJ; Kim YG; Kim B; Seong MW; Kim BJ; Lee C; Kwak Y; Chung HJ; Virós A; Lee DY
J Eur Acad Dermatol Venereol; 2022 May; 36(5):651-660. PubMed ID: 35098589
[TBL] [Abstract] [Full Text] [Related]
9. Early-Onset Spinal Deformity in Neurofibromatosis Type 1: Natural History, treatment, and Imaging Surveillance.
Marrache M; Suresh KV; Miller DJ; Hwang S; Schorry EK; Rios JJ; Sponseller PD
JBJS Rev; 2021 Jul; 9(7):. PubMed ID: 34297709
[TBL] [Abstract] [Full Text] [Related]
10. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
[TBL] [Abstract] [Full Text] [Related]
11. Are Some Randomized Clinical Trials Impossible?
Rios JJ; Richards BS; Stevenson DA; Oberlander B; Viskochil D; Gross AM; Dombi E; Widemann BC; Plotkin SR; May CJ; Ullrich NJ; Goldstein RY; Jain V; Schorry EK;
J Pediatr Orthop; 2021 Jan; 41(1):e90-e93. PubMed ID: 32852366
[TBL] [Abstract] [Full Text] [Related]
12. A molecular basis for neurofibroma-associated skeletal manifestations in nf1.
Ma Y; Gross AM; Dombi E; Pemov A; Choi K; Chaney K; Rhodes SD; Angus SP; Sciaky N; Clapp DW; Ratner N; Widemann BC; Rios JJ; Elefteriou F
Genet Med; 2020 Nov; 22(11):1786-1793. PubMed ID: 32601387
[TBL] [Abstract] [Full Text] [Related]
13. [Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
Liao ZC; Zhang C; Liu XY; Ren ZW; Xu J; Zhang CZ; Yang Y; Zhu Z; Yang JL
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):648-653. PubMed ID: 31550853
[TBL] [Abstract] [Full Text] [Related]
14. Pathological fracture of non-ossifying fibroma associated with neurofibromatosis type 1.
Gill JR; El Nakhal TM; Park SM; Chomicki M
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31331926
[TBL] [Abstract] [Full Text] [Related]
15. The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin treatment.
Brady SW; Ma X; Bahrami A; Satas G; Wu G; Newman S; Rusch M; Putnam DK; Mulder HL; Yergeau DA; Edmonson MN; Easton J; Alexandrov LB; Chen X; Mardis ER; Wilson RK; Downing JR; Pappo AS; Raphael BJ; Dyer MA; Zhang J
Mol Cancer Res; 2019 Apr; 17(4):895-906. PubMed ID: 30651371
[TBL] [Abstract] [Full Text] [Related]
16. Intracranial malignant peripheral nerve sheath tumor variant: an unusual neurovascular phenotype sarcoma case invading through the petrous bone.
Mrowczynski OD; Greiner RJ; Kapadia M; Fanburg-Smith JC; Iantosca MR; Rizk EB
Childs Nerv Syst; 2018 Aug; 34(8):1605-1608. PubMed ID: 29616298
[TBL] [Abstract] [Full Text] [Related]
17. A brief report of plexiform neurofibroma.
Khajavi M; Khoshsirat S; Ahangarnazari L; Majdinasab N
Curr Probl Cancer; 2018; 42(2):256-260. PubMed ID: 29449010
[TBL] [Abstract] [Full Text] [Related]
18. Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.
Kraniak JM; Chalasani A; Wallace MR; Mattingly RR
Exp Neurol; 2018 Jan; 299(Pt B):289-298. PubMed ID: 29055717
[TBL] [Abstract] [Full Text] [Related]
19. Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.
Park HS; Park SN; Im K; Kim SM; Kim JA; Hwang SM; Lee DS
Br J Haematol; 2017 Aug; 178(4):603-615. PubMed ID: 28699658
[TBL] [Abstract] [Full Text] [Related]
20. Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Kolberg M; Bruun J; Murumägi A; Mpindi JP; Bergsland CH; Høland M; Eilertsen IA; Danielsen SA; Kallioniemi O; Lothe RA
Mol Oncol; 2017 Sep; 11(9):1156-1171. PubMed ID: 28556483
[TBL] [Abstract] [Full Text] [Related]
[Next]
